To explore possible associations between microglial and astroglial activation and clinical features of MS, we investigated whether the CSF levels of GFAP and sTREM2 correlated with specific demographic and clinical characteristics at the time of MS diagnosis. This evidence concerns the gene GFAP and myeloid sarcoma.